3 March 2017: The Federal Ministers give a final decision (positive) for this trialFile: b_be_16_bvw1_authorisation.pdfTrial reference: A Phase 1, Multicenter, Open-label Trial to Evaluate the Safety of TalimogeneDoc type: Information related to the decision procedure
